Supermodel Bambi Northwood-Blyth wears a Dexcom glucose monitor. So does your next-door neighbor with type 2 diabetes and ...

DexCom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, is ushering in the next era of transformative, ...

DexCom overview and recent share performance DexCom (DXCM) has drawn fresh attention as investors reassess its continuous glucose monitoring business and recent share performance, with the stock last ...

Lingo is Abbott’s over-the-counter continuous glucose monitor (CGM) for nondiabetic people. Withings users will also be able ...

Now, it’s worth noting Stock Advisor’s total average return is 991 % — a market-crushing outperformance compared to 196% for ...

Wednesday, January 7, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Micron ...

Bank of America Securities analyst Travis Steed maintained a Buy rating on Dexcom today and set a price target of $100.00. According to TipRanks, Steed is a 4-star analyst with an average return of ...

These technologies are improving all the time. If they’re not making claims that they are medical grade, let’s let the market ...

Wearable health devices may soon operate under looser regulatory oversight following new guidance from the FDA ...

The Traitors spin-off host, Ed Gamble, had his whole world changed when he was just 13 years old. The youngster caught a nasty cold, but a more serious diagnosis came off the back of it.

The U.S. FDA will limit its regulation of health and fitness wearables, clarifying that low-risk wellness devices, such as ...

DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to ...